Literature DB >> 6815108

The kinetics of cefuroxime in ascitic and pleural fluid.

A Lechi, E Arosio, L Xerri, C Mengoli, G Montesi, O Ghidini.   

Abstract

Adequate drug concentration at the infection site is a very important objective of antibiotic therapy. In this study we investigated the pharmacokinetics of the new methoximine, cefuroxime, in peritoneal and pleural fluids in 16 patients. After a 1-g dosage of cefuroxime, its concentration reaches a peak in ascitic fluid within 4-5 h. With a 2-g dose the peak level is reached in 2-3 h. After 5 h, cefuroxime concentration in ascites exceeds that in serum. Cefuroxime diffuses readily into the peritoneal space, where high concentrations (8-10 mcg/ml) are maintained for at least 6 h. Data on the kinetics in pleural fluid also seem to show high antibiotic diffusion rates, even if concentrations are never as high as those in blood at the same time following 1 g i.v. These favorable kinetic properties are probably due to low serum protein binding and to slow renal excretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815108

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  5 in total

Review 1.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

Review 2.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Distribution of ceftazidime in ascitic fluid.

Authors:  G Benoni; E Arosio; M G Raimondi; E Apolloni; E Passarella; A Lechi; G P Velo
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

4.  Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.

Authors:  M J Otero; M J Garcia; M Barrueco; A Dominguez-Gil; F Gomez; J Portugal Alvarez
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Penetration and clearance of cefoperazone and moxalactam in pleural fluid.

Authors:  H Yamada; T Iwanaga; H Nakanishi; M Yamaguchi; K Iida
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.